Contacts | Pfizer Benefits   
 
  • Stay Informed
  • Get Involved
  • Be Healthy
  • Know Your Benefits
  • Visit Community Corner
    •

Focus On... Heat Stroke

With the summer entering mid-season, heat and humidity are on the rise and so is the risk for heat stroke.


Read more

Get Healthy, Stay Healthy:
Skin Health

Keep up with skin care to make sure your skin is at its healthiest. Learn about skin cancer prevention, sun protection and more.


Read more

Three Ways to Be Smarter This Summer

If you find yourself feeling mentally sharper as the days get longer, warmer and sunnier, that may not be your imagination. With more light and possibly more time, the summer may be a perfect time to strengthen your brainpower.


Read more

Summer Foot Care

The arrival of summer means that after months of being confined in boots and shoes your feet can finally be set free.


Read more

Get Inspired, Get Old

We believe your later years should be celebrated. Join us in changing attitudes about getting older.


Read more

Historic Pfizer Images


View Gallery

Items of Interest

Visit the Community Corner

Read Retiree Spotlights, learn about upcoming events and more!

Pfizer Zero Cost Drug List

An updated Pfizer Zero Copay Drug List / Greenstone Generic Drug List is now available. (September 2016)
PREVENTIVE CARE: WHAT YOU SHOULD KNOW
Preventive care services include lab tests, screenings, exams, and vaccines. These services can help find health problems early when they often are most treatable, or can keep you from getting certain diseases or illnesses.
Read more >>

Pfizer News


  • Merck and Pfizer Collaborate with Corning
    Thu, 20 Jul 2017
  • Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole)
    Thu, 20 Jul 2017
  • Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
    Thu, 13 Jul 2017
  • FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
    Tue, 11 Jul 2017
  • BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
    Fri, 30 Jun 2017
  • Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri
    Tue, 27 Jun 2017
  • Pfizer Declares 32-Cent Third-Quarter 2017 Dividend
    Thu, 22 Jun 2017

There's no one way to

Fear Less. Live Longer.

Get Inspired & Learn More

Join the Pfizer Plus Community Corner

When you join the PfizerPlus.com community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • PfizerPlus.com Community

Sign Up Now

Member Sign-In
Copyright © 2017 Pfizer Inc All Rights Reserved | Contact Us | Terms of Use | Privacy Statement